Entity
  • TargEDys

    Created in 2015
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    2,708
  • Activities

  • Technologies

  • Entity types

  • Location

    Administration Bibliothèque, 22 Bd Gambetta, 76000 Rouen, France

    Rouen

    France

  • Employees

    Scale: 11-50

    Estimated: 10

  • Engaged corporates

    5
    1 4
  • Added in Motherbase

    5 years, 6 months ago
Description
  • Value proposition

    From Probiotics to PreciBiomics


    TargEDys is a French commercial-stage biotech company specialized in the development of precision probiotics, or PreciBiomic solutions. Our mission is to detect, transpose and make available microbiome-based innovations to answer global public health challenges.
    How? By translating microbiome fundamental research from prestigious French institutes such as the Inserm and IGFL to applied research in probiotics, understanding the molecular mechanism of action of our strains, and developing industrial processes and IP to propose turnkey science-backed probiotics.
    Our vision is to bring the microbiome to the heart of healthcare and harvest its immense potential to improve the quality of life through appetite regulation, nutritional optimization, and mental wellness.

    Microbiome, Overweight, Obesity, Anorexia, Cachexia, probiotics, Appetite regulation, Hafnia alvei, Metabolic Diseases, Growth, L. plantraum WJL, Protein absorption, Molecular mimetism, PreciBiomic, Precision probiotics, and ClpB

  • Original language

    From Probiotics to PreciBiomics


    TargEDys is a French commercial-stage biotech company specialized in the development of precision probiotics, or PreciBiomic solutions. Our mission is to detect, transpose and make available microbiome-based innovations to answer global public health challenges.
    How? By translating microbiome fundamental research from prestigious French institutes such as the Inserm and IGFL to applied research in probiotics, understanding the molecular mechanism of action of our strains, and developing industrial processes and IP to propose turnkey science-backed probiotics.
    Our vision is to bring the microbiome to the heart of healthcare and harvest its immense potential to improve the quality of life through appetite regulation, nutritional optimization, and mental wellness.

Corporate interactions BETA
Corporate TypeTweets Articles
Ipsos France
Ipsos France
Polling institute, Research Services
Ipsos France
Polling institute, Research Services
Other

18 Jul 2023


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Other

1 May 2023


La Tribune
La Tribune
Media, Newspapers
La Tribune
Media, Newspapers
Other

4 Feb 2023


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

4 Feb 2023


Seventure Partners
Seventure Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Seventure Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Capitalistic
Partnership
Not event

25 May 2023


Similar entities
Loading...
Loading...
Social network dynamics